everio airmaster 50 mikrogramov/500 mikrogramov
zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
seretide diskus 50 mikrogramov/500 mikrogramov
glaxosmithkline trading services limited, Írsko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
seretide diskus 50 mikrogramov/250 mikrogramov
glaxosmithkline trading services limited, Írsko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
seretide diskus 50 mikrogramov/100 mikrogramov
glaxosmithkline trading services limited, Írsko - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica
foster nexthaler 200/12 mikrogramov/dávka
chiesi pharmaceuticals gmbh, rakúsko - formoterol a beklometazón - 14 - bronchodilatantia, antiasthmatica
airexar spiromax
teva b.v. - salmeterol, fluticasone propionát - pulmonary disease, chronic obstructive; asthma - drogy obštrukčnej choroby dýchacích ciest, - airexar spiromax je indikovaný na použitie len u dospelých vo veku 18 rokov a viac. asthmaairexar spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting β2 agonist) is appropriate:- patients not adequately controlled on a lower strength corticosteroid combination productor- patients already controlled on a high dose inhaled corticosteroid and long-acting β2 agonist. s chronickou obštrukčnou chorobou (chochp)airexar spiromax je indikovaný na liečbu symptomatických pacientov s chochp, s fev1.
salmeterol/flutikazón cipla 25 mikrogramov/250 mikrogramov/dávka
cipla europe nv - salmeterol a iné antiastmatiká - 14 - bronchodilatantia, antiasthmatica
salmeterol/flutikazón cipla 25 mikrogramov/125 mikrogramov/dávka
cipla europe nv - salmeterol a iné antiastmatiká - 14 - bronchodilatantia, antiasthmatica
cinqaero
teva b.v. - reslizumab - astma - ostatné systémové lieky obštrukčnej choroby dýchacích ciest, - cinqaero je indikovaný ako prídavná liečba u dospelých pacientov s ťažkou astmou kompenzáciou napriek vysokej dávke vdychované kortikosteroidy plus s iným liekom na udržiavaciu liečbu.
nucala
glaxosmithkline trading services - mepolizumab - astma - drogy obštrukčnej choroby dýchacích ciest, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.